FREDUN logo

Fredun Pharmaceuticals L

FREDUN·BSE·
1,478.00 -10.30 (-0.69%)
Market Cap397.59 Cr
PE Ratio100.89
Volume13,974
Day High - Low1517.00 - 1468.10
52W High-Low1590.00 - 1400.00
DocStoX Score
4.7/10
Weak
Fair Value
Sign in to see
ROE
14.80%
Average
P/E
100.89x
Expensive
Debt / Equity
0.80
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day1468
1517
52W1400
1590
DocStoX take

Supported by growth (10.0), but held back by valuation (0.0). Growth looks strong at 10.0, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.7
/10
Weak
Quality
Solid
ROE 14.8%
Valuation
Expensive
P/E 100.9×
Growth
Strong
Revenue +36.7% 5Y CAGR
Risk
Elevated
D/E 0.80
Momentum
Soft
41% of 52-week range

At a glance

Market Cap
₹398 Cr
52W High / Low
₹1590 / ₹1400
Dividend Yield
0.05%
Promoter Holding
44.57%
EPS (TTM)
₹14.65
Book Value
₹162.78

Key highlights

  • Profit compounding 75% a year
  • Revenue compounding 37% a year
  • Profitable in all of the last 5 years
  • Valuation is weak (0.0/10)
  • Expensive at 101× earnings
3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

FREDUN PHARMACEUTICALS L peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.